Elan Pharmaceuticals is a biopharmaceutical company based in the United States, known for developing innovative therapies for neurological and autoimmune diseases. Founded in 1969, the company focuses on research and development to create treatments that improve patients' quality of life. In 2013, Elan Pharmaceuticals was acquired by Perrigo Company, which expanded its portfolio in the healthcare sector. The company has been involved in the development of drugs for conditions such as Alzheimer's disease and multiple sclerosis, contributing to advancements in medical science and patient care.